ARTICLE | Management Tracks
MorphoSys’ CFO Lee leaving
Plus: Mestag names Logtenberg as chair and updates from Edgewise, Myriad and Venatorx
December 20, 2022 11:09 PM UTC
MorphoSys AG (NASDAQ:MOR; Xetra:MOR) said that CFO Sung Lee had decided to leave the company and move back to California for personal reasons, effective March 17, 2023. A search for the successor is ongoing. Lee, a 13-year veteran of Gilead Sciences Inc. (NASDAQ:GILD), moved to Germany to join MorphoSys in 2021.
Cambridge, U.K.-based cancer and inflammatory disease company Mestag Therapeutics Ltd. named Ton Logtenberg, a director, chair. He succeeds Houman Ashrafian, the managing partner at SV Health Investors, who will continue as board member. Logtenberg founded Merus N.V. (NASDAQ:MRUS), where he was president and CEO. ...